[go: up one dir, main page]

AU2017900494A0 - Formulations of Cannabindoids for the Treatment of Psoriasis - Google Patents

Formulations of Cannabindoids for the Treatment of Psoriasis

Info

Publication number
AU2017900494A0
AU2017900494A0 AU2017900494A AU2017900494A AU2017900494A0 AU 2017900494 A0 AU2017900494 A0 AU 2017900494A0 AU 2017900494 A AU2017900494 A AU 2017900494A AU 2017900494 A AU2017900494 A AU 2017900494A AU 2017900494 A0 AU2017900494 A0 AU 2017900494A0
Authority
AU
Australia
Prior art keywords
cannabindoids
psoriasis
formulations
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017900494A
Inventor
Matthew CALLAHAN
Eugene Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Botanix Pharmaceuticals Inc
Original Assignee
Botanix Pharmaceuticals Inc
Filing date
Publication date
Application filed by Botanix Pharmaceuticals Inc filed Critical Botanix Pharmaceuticals Inc
Publication of AU2017900494A0 publication Critical patent/AU2017900494A0/en
Priority to CA3053505A priority Critical patent/CA3053505A1/en
Priority to US16/486,297 priority patent/US20220313621A1/en
Priority to BR112019017011A priority patent/BR112019017011A2/en
Priority to AU2018221882A priority patent/AU2018221882A1/en
Priority to JP2019544844A priority patent/JP2020508991A/en
Priority to CN201880023266.4A priority patent/CN110520123A/en
Priority to EP18754611.4A priority patent/EP3582769A4/en
Priority to PCT/AU2018/050047 priority patent/WO2018148787A1/en
Priority to IL26873319A priority patent/IL268733A/en
Abandoned legal-status Critical Current

Links

AU2017900494A 2017-02-15 2017-02-15 Formulations of Cannabindoids for the Treatment of Psoriasis Abandoned AU2017900494A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA3053505A CA3053505A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of psoriasis
US16/486,297 US20220313621A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of psoriasis
BR112019017011A BR112019017011A2 (en) 2017-02-15 2018-01-24 cannabinoid formulations for the treatment of psoriasis
AU2018221882A AU2018221882A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of psoriasis
JP2019544844A JP2020508991A (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of psoriasis
CN201880023266.4A CN110520123A (en) 2017-02-15 2018-01-24 For treating the cannabinoid formulation of psoriasis
EP18754611.4A EP3582769A4 (en) 2017-02-15 2018-01-24 CANNABINOID FORMULATIONS FOR THE TREATMENT OF PSORIASIS
PCT/AU2018/050047 WO2018148787A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of psoriasis
IL26873319A IL268733A (en) 2017-02-15 2019-08-15 Formulations of cannabinoids for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
AU2017900494A0 true AU2017900494A0 (en) 2017-03-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP3448874A4 (en) Compositions for the treatment of disease
EP3448987A4 (en) Compositions for the treatment of disease
EP3634417A4 (en) Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
EP3481402A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3484504A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3490561A4 (en) Combinations for the treatment of cancer
EP3174525A4 (en) Otic formulations for the treatment of ceruminosis
EP3503887A4 (en) Combinations for the treatment of cancer
EP3548007A4 (en) Methods for the treatment of cancer
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
EP3256124A4 (en) Cenicriviroc for the treatment of fibrosis
PL3448340T3 (en) Application aid for the treatment of wounds
EP3813872A4 (en) Compositions for the treatment of skin conditions
EP3630754B8 (en) Isoindoline-acetylene compounds for the treatment of cancer
EP3448377A4 (en) Methods for the treatment of infection
EP3242681B8 (en) Novel compounds for the treatment of cancer
PT3340975T (en) Formulation for the treatment of acne
EP3694521A4 (en) Methotrexate topical solution for treatment of psoriasis
EP3507277B8 (en) Hydroxynorketamine derivatives for the treatment of disorders
EP3634395A4 (en) Formulations of lixivaptan for the treatment of polycystic disease
HK40107870A (en) Esketamine for the treatment of depression
AU2017900494A0 (en) Formulations of Cannabindoids for the Treatment of Psoriasis
HK40101362A (en) Azolopyrimidine for the treatment of cancer-related disorders
HK40120600A (en) Formulations of brincidofovir
HK40115807A (en) Formulations of brincidofovir